EPISODE · Feb 21, 2023 · 21 MIN
Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up
from BioCentury This Week · host BioCentury
On the latest BioCentury This Week podcast, BioCentury’s editors discuss what the latest payment models from CMS could mean for cell and gene therapies, and how a new model could incentivize the completion of confirmatory trials for drugs with accelerated approval. BioCentury's editors also discuss the outlook for China's public markets and details around the genetic medicine delivery technology of recently launched Aera Therapeutics.Reach us by sending a text
What this episode covers
On the latest BioCentury This Week podcast, BioCentury’s editors discuss what the latest payment models from CMS could mean for cell and gene therapies, and how a new model could incentivize the completion of confirmatory trials for drugs with accelerated approval. BioCentury's editors also discuss the outlook for China's public markets and details around the genetic medicine delivery technology of recently launched Aera Therapeutics. Reach us by sending a text
NOW PLAYING
Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m